Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhanqi Liu

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 19, 2025
Highly Oriented Bio-Mimetic Hydrogels by CalenderingZhanqi Liu, Yuqing Wang, Haidi Wu, et al.
Cancer Immunity|February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanomaAndrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Mabs|April 1, 2016
Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptorIngrid J G Burvenich, William Farrugia, Fook T Lee, et al.
Cancer Immunity|August 21, 2007
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinomaIan D Davis, Zhanqi Liu, Wayne Saunders, et al.
Chemical Communications (Cambridge, England)|February 22, 2023
Bromodomain and extraterminal protein-targeted probe enables tumour visualisation <i>in vivo</i> using positron emission tomographyCatherine G Fitzgerald Dickmann, Alexander F McDonald, Nhi Huynh, et al.
Growth Factors (Chur, Switzerland)|November 21, 2012
Ligand binding induces a conformational change in epidermal growth factor receptor dimersFrancesca Walker, Julie Rothacker, Christine Henderson, et al.
Cancer Immunity|August 21, 2007
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinomaIan D Davis, Gregory A Wiseman, Fook-Thean Lee, et al.
Theranostics|August 22, 2018
Molecular imaging of T cell co-regulator factor B7-H3 with <sup>89</sup>Zr-DS-5573aIngrid Julienne Georgette Burvenich, Sagun Parakh, Fook-Thean Lee, et al.
Molecular Cancer Therapeutics|May 13, 2025
Characterization of mAb104, a Monoclonal Antibody Targeting a Conformationally Exposed, Tumor-specific epitope of HER2Sagun Parakh, Nhi Huynh, Diana Dong Cao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 20, 2021
Radiolabelling and preclinical characterization of <sup>89</sup>Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfaIngrid Julienne Georgette Burvenich, Yit Wooi Goh, Nancy Guo, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 19, 2025
Highly Oriented Bio-Mimetic Hydrogels by CalenderingZhanqi Liu, Yuqing Wang, Haidi Wu, et al.
Cancer Immunity|February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanomaAndrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Mabs|April 1, 2016
Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptorIngrid J G Burvenich, William Farrugia, Fook T Lee, et al.
Cancer Immunity|August 21, 2007
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinomaIan D Davis, Zhanqi Liu, Wayne Saunders, et al.
Chemical Communications (Cambridge, England)|February 22, 2023
Bromodomain and extraterminal protein-targeted probe enables tumour visualisation <i>in vivo</i> using positron emission tomographyCatherine G Fitzgerald Dickmann, Alexander F McDonald, Nhi Huynh, et al.
Growth Factors (Chur, Switzerland)|November 21, 2012
Ligand binding induces a conformational change in epidermal growth factor receptor dimersFrancesca Walker, Julie Rothacker, Christine Henderson, et al.
Cancer Immunity|August 21, 2007
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinomaIan D Davis, Gregory A Wiseman, Fook-Thean Lee, et al.
Theranostics|August 22, 2018
Molecular imaging of T cell co-regulator factor B7-H3 with <sup>89</sup>Zr-DS-5573aIngrid Julienne Georgette Burvenich, Sagun Parakh, Fook-Thean Lee, et al.
Molecular Cancer Therapeutics|May 13, 2025
Characterization of mAb104, a Monoclonal Antibody Targeting a Conformationally Exposed, Tumor-specific epitope of HER2Sagun Parakh, Nhi Huynh, Diana Dong Cao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 20, 2021
Radiolabelling and preclinical characterization of <sup>89</sup>Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfaIngrid Julienne Georgette Burvenich, Yit Wooi Goh, Nancy Guo, et al.
Pageof 5